Auransa

auransa.com

We are a clinical-stage, AI-native biopharma that mines massive data for therapeutic gold to raise the standard of cancer care. Our platform uses AI and available, heterogeneous human disease data to uncover novel drug candidates for the most responsive patients, leading to smarter drug discovery that maximizes clinical trial success. We are currently focused on advancing better therapies for cancers and cancer-related diseases. Our lead program, AU-409, for liver cancer, is in Phase 1 clinical studies.